Investigational blood test identifies patients with melanoma who are more likely to have improved survival on nivolumab therapy

Biodesix, Inc. has announced new clinical findings showing that its novel investigational test, BDX008, based on profiling serum proteins, identifies patients with advanced melanoma who are more...